Company intelligence / Profile preview
Kissei Pharmaceutical Co., Ltd.
Matsumoto, Nagano, Japankissei.co.jp ↗
- Ownership
- Public · 4565.T
- Employees
- ~1333
- Development stage
- Commercial
01
Overview
Kissei has multiple approved products on the market and a robust pipeline with candidates in various stages of development, from Phase II to NDA preparation. Their key focus areas include urology, dialysis, women's health, ophthalmology, endocrinology, and metabolism.
- Therapeutic areas
- PulmonologyMen's HealthEndocrinologyImmunologyHematologyWomen's HealthOncologyNeurology
- Modalities
- Small molecule drugsRecombinant proteinsPolymersOncolytic viruses
- Industry
- Biotech
02
Drug pipeline
26 assets25 more assets in the full pipeline.
03
Partnerships
CG Oncology (U.S.)Shionogi (Japan)Theramex (U.K.)JW Pharmaceutical (Korea)Synmosa Biopharma (Taiwan)Eisai (Japan)Reborna BiosciencesRigel Pharmaceuticals
Beyond the preview
Go deeper on Kissei Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kissei Pharmaceutical Co., Ltd..